Quick Links

 George Somlo, M.D., F.A.C.P.
  • Breast Oncology, Breast Cancer Team
  • Director and Professor, Breast Oncology and High-Dose Therapeutics, Medical Oncology & Therapeutics Research
  • Staff Physician, Hematology & Hematopoietic Cell Transplantation
  • Member, Developmental Cancer Therapeutics Program, Comprehensive Cancer Center
  • Professor of Medical Oncology

Professional Experience

2004 - present, Director, Breast Oncology and Director, High Dose Therapeutics. Professor, Department of Medical Oncology & Therapeutics Research, City of Hope, Duarte, CA

2004 - 2012, Co-director, Breast Cancer Program, City of Hope, Duarte, CA

2003 - present, Director, Multiple Myeloma Program, Staff Physician, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA

1998 - present, Member, Breast Cancer Guideline Panel, National Comprehensive Cancer Network

Education and Training

1985 - 1988, City of Hope, Duarte, CA. Fellow, Medical Oncology, Department of Medical Oncology & Therapeutics Research and Department of Hematology & Hematopoietic Cell Transplantation.

1982 - 1985, University of California, Irvine and Long Beach, VAMC, Internship and Residency in Internal Medicine.

1972 - 1978, University of Semmelweis Medical School, Budapest, Hungary


This is an abbreviated document. Full CV available upon request. Information on this page may be self-reported. Last updated: 05/12
George Somlo, M.D., F.A.C.P.

 Learn More

My Clinical Trials
My Selected Publications

My Clinical Expertise and Interests:

  • Translational research in breast cancer: Prognostic and predictive indicators of outcome and response to therapy based on the biology of primary tumors.
  • Developmental therapeutics: Target indentification; phase I-II drug development with emphasis on incorporating novel agents into the treatment of breast cancer, sarcomas, and other solid tumors.
  • Multiple Myeloma: The role of autologous and allogeneic stem cell transplantation; identification of targets, incorporation of novel therapeutic agents into the treatment fo myeloma.
  • Stem cell biology: Emphasis on incorporating new cytokines as mobilizing and protective agents of hematopoietic stem cells; redefining the role of dose-intense chemo/radiotherapy and stem cell transplantation for breast cancer; target imaging by utilizing radiolabeled antibodies.

 Search
Go!
Advanced Search Options
News & Publications Search

 Contact Information

To request expert commentary on Breast Cancer, Mammography, or Medical Oncology, contact Media Relations.

To schedule an appointment, call 800-826-HOPE (4673) or complete our online form.
© 2012 City of Hope.
1500 East Duarte Road
Duarte, California 91010
626-256-HOPE (4673)
NCI CCC LogoCity of Hope is one of 40 Comprehensive Cancer Centers, the highest designation bestowed by the National Cancer Institute and a recognition of excellence in cancer treatment, research, prevention and education.
City of Hope strongly supports and values the uniqueness of all individuals and promotes a work environment where diversity is embraced.
NCI CCC LogoThe National Comprehensive Cancer Network®
(NCCN), a not-for-profit alliance of 21 of the world’s leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer.
Best Of logoWe subscribe to the HON code of the Healthcare on the Net Foundation.